Скачать с ютуб NCCN Patient Webinar: Advanced and Metastatic Bladder Cancer в хорошем качестве

NCCN Patient Webinar: Advanced and Metastatic Bladder Cancer

Experts discuss understanding advanced and metastatic bladder cancer and its various treatment options, how to engage in shared decision-making, clinical trials, getting a second opinion, and tips for navigating patient and caregiver resources. Topics Discussed 00:00 Welcome 01:59 Introduction and NCCN Guidelines® for Bladder Cancer 04:02 Urothelial carcinoma 04:36 Incidence and mortality 07:15 Staging 09:53 Common symptoms and risk factors 11:48 Diagnostic evaluation and office cystoscopy 12:46 Papillary tumor 13:58 Patient counseling 14:53 Transurethral resection 15:58 Intravesical therapy 16:46 Radical cystoprostatectomy 18:24 Nerve-sparing cystectomy and organ-sparing cystectomy 20:07 Pelvic lymph node dissection 20:39 Outcomes after cystectomy 21:10 Neoadjuvant chemotherapy 22:02 Urinary diversion, neobladder, and continent cutaneous diversion 24:10 Importance of multidisciplinary care 24:48 Systemic therapy 27:17 Preoperative (neoadjuvant) chemotherapy 28:54 Comparing outcomes with chemotherapy regimens 31:23 Upper tract urothelial carcinoma 32:15 Postoperative (adjuvant) chemotherapy 33:51 Comparing postoperative chemotherapy versus placebo 35:22 Therapy for recurrent and metastatic cancer 37:50 Overview of FDA approved agents 42:55 Evolving standard of care and emerging data 46:37 Cost of care and review 49:20 Helpful resources, including NCCN Guidelines for Patients® 54:19 Bladder Cancer Advocacy Network (BCAN) 59:02 World Bladder Cancer Patient Coalition 59:54 Finding clinical trials 1:02:07 Guidance from bladder cancer survivor Q&A Session 1:06:06 Can you speak more about side effects of TURBT (transurethral resection of bladder tumor) and paralysis? 1:08:09 What is the age of people having procedures and life expectancy after some of the procedures? 1:09:56 Is chemo the first line of therapy rather than surgery? 1:11:52 Who else can help make treatment decisions and how long does a patient have to make a decision? 1:15:39 Why can’t urine be diverted to the rectum after the bladder is removed? 1:17:03 If you receive neoadjuvant chemo and then your bladder cancer recurs do you use the same agent? How are those decisions made? 1:18:50 Can you provide clarity about the price of treatment? 1:20:55 Where can people seek assistance for paying for treatment? The Patient Webinar on Advanced and Metastatic Bladder Cancer occurred in February 2024. This program was created in conjunction with the NCCN Guidelines for Patients® for Bladder Cancer: https://www.nccn.org/patientresources... The NCCN Guidelines for Patients are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee. NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician. Supporters: This webinar is supported through the NCCN Foundation and by contributions from our corporate supporter: EMD Serono, Inc. __________________________________________________________ About NCCN Foundation®: NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation __________________________________________________________ About NCCN: The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information. Subscribe to our channel: https://www.youtube.com/c/NCCNvideo?s... Connect with us! X:   / nccn   LinkedIn:   / nccn   Facebook:   / nccnorg   Instagram:   / nccnorg